Today's most striking scene was Delta Air Lines proving that guidance beats headline surprises. EPS of $1.56 topped the $1.49 consensus by 6% and revenue also beat, yet shares fell 1.81% — third-quarter guidance and rising fuel-cost concerns overwhelmed the headline beat. Meta moved the market in the opposite fashion: a single cloud-business announcement, 'Meta Compute,' sent shares up 6% and roughly 15% for the week, its best week since early 2024. That's not earnings-driven — it's a narrative that reframes capex as a revenue stream, and investors bought it. SK Hynix's Nasdaq debut is equally notable: the largest-ever US listing by a foreign company, worth $29 billion, opened at a 12.8% premium to its offering price, signaling that investor appetite for the semiconductor rally remains solid. Still, SPCX's -4.51% and Gilead's -3.72% (on a failed Phase 3 trial) are reminders that single-stock risk remains elevated.
📊 Top Movers
🧭 Sector Performance
🇰🇷 Korean Investor Perspective
The USD/KRW edged up 2.56 won to 1,505.91, snapping a five-session losing streak. Today's biggest event was SK Hynix's Nasdaq ADR listing — the largest-ever US listing by a foreign company at $29 billion, opening at a 12.8% premium to its $149 offering price and drawing heavy attention from Korean investors. Note it trades under the temporary ticker SKHYV until converting to SKHY on July 13. Meta's cloud business expansion (+5.97%) is a positive read-through for semiconductor demand expectations benefiting SK Hynix and Samsung. QQQ edged up with the Nasdaq's +0.29%, while SPCX (-4.51%) continued its correction on bond-offering and lockup-expiration concerns — holders should watch the insider share unlock schedule expected in August and September.
📊 Market Overview
Wall Street closed out a turbulent week on a high note. The S&P 500 rose to 7,575.39 (+0.42%), nearing record territory, while the Nasdaq gained to 26,281.61 (+0.29%) and the Dow added 149.60 points to 52,637.01 (+0.29%).
Friday's session had two headline stories. First, Meta Platforms jumped 5.97% on the announcement of its 'Meta Compute' cloud business, capping a roughly 15% weekly gain — its best week since early 2024. Second, SK Hynix listed ADRs on Nasdaq in a $29 billion offering, the largest-ever US listing by a foreign company. Delta Air Lines, meanwhile, fell despite an earnings beat, reconfirming the market's 'guidance over headline beat' principle.
🔑 Key Issues
1. Meta +5.97% — 'Meta Compute' cloud business unveiled Meta unveiled Meta Compute, a new cloud business selling AI computing power and models directly, positioning it to compete head-on with AWS, Azure, Google Cloud, and CoreWeave. The narrative reframes massive data center capex as a revenue driver rather than pure cost. The news coincided with reports that in-house 'Iris' AI chip production begins in September targeting roughly 14GW of capacity next year, plus rollout of new Muse Spark and Muse Image AI models across Instagram, WhatsApp, and ads. The roughly 15% weekly gain marks Meta's best week since early 2024.
2. SK Hynix Nasdaq ADR debut — largest-ever US listing by a foreign company SK Hynix held an opening bell ceremony at the Nasdaq MarketSite in Times Square to begin ADR trading. Priced at $149/ADR raising $26.5B, the offering saw orders covering seven times the shares on offer. Shares opened at $170, a 12.8% premium to the offering price, confirming strong investor demand. Trading occurs under the temporary ticker SKHYV until converting to SKHY on July 13; ten ADRs represent one underlying common share.
3. Delta falls despite earnings beat — guidance overrides the headline Delta reported Q2 adjusted EPS of $1.56, beating the $1.49 consensus by 6.1%, with revenue of $17.67B also topping the $17.53B estimate. Free cash flow of $1.4B supported a 15% dividend hike. Yet shares fell 1.81%, as investors focused on Q3 EPS guidance ($2.00 to $2.50) and rising fuel-cost concerns rather than the beat itself — reconfirming that the market weighs forward outlook more heavily than the last quarter's results.
4. Gilead -3.72% — failed Phase 3 oncology trial Gilead Sciences fell sharply after a Phase 3 solid tumor trial failure. Its TROP2-targeted antibody-drug conjugate has been central to the company's growth thesis, and the setback triggered a market re-pricing of success odds for future label expansions. Rising Treasury yields on strong jobs data added pressure across biotech valuations broadly.
5. SPCX -4.51% — bond offering and lockup concerns persist SPCX extended its correction on lingering concerns from the surprise $25 billion bond offering on June 22-23 and upcoming insider share lockup expirations in August and September. Up to 20% of insider shares could unlock after the August earnings report, with up to 44% potentially free to trade by early September — a scenario that could expand the float by up to 900%. Shares remain 26% below their post-IPO high.
📊 Sector Trends
| Sector | Change | Driver |
|---|---|---|
| Communications | +3.4% | Meta's cloud business surprise |
| Semiconductors | +1.8% | SK Hynix listing excitement, Nvidia/AMD strength |
| Technology | +1.2% | Continued AI infrastructure strength |
| Consumer Staples | +0.5% | Defensive strength led by Walmart |
| Industrials | -0.3% | Mixed |
| Healthcare | -1.9% | Gilead's trial failure, rising Treasury yields |
| Airlines/Travel | -2.0% | Weakness following Delta's guidance concerns |
🌍 Global Markets
- Dollar Index (DXY): Modestly firmer on resilient jobs data
- 10-Year Treasury Yield: Around 4.55-4.56%, edging up on strong employment data
- WTI Crude: Continued rising-fuel-cost concerns as flagged in Delta's guidance
- Gold: Range-bound amid higher yields
- USD/KRW: 1,505.91 (+2.56) — five-session losing streak snapped
🚀 SPCX (SpaceX) Watch
SPCX fell to $145.30 (-4.51%), giving back two days of rebound gains. The surprise $25 billion bond offering on June 22-23 heightened investor concern over repayment burden, and renewed attention to a specific unlock schedule — 20% of insider shares after August earnings, up to 44% by early September — added selling pressure. Some analysts view the IPO valuation as excessive, projecting negative free cash flow for years ahead. Shares are down 26% from their post-IPO high, with volatility likely to increase as the lockup dates approach.
⚠️ Investor Caution
Today reaffirmed that narrative beats numbers. Delta beat earnings but the stock lost; Meta jumped 6% on a business announcement, not results. In this environment, entering trades purely on headline beats carries real risk. SK Hynix's ADR showed strong first-day demand, but liquidity during the temporary-ticker period may differ from after regular trading begins (7/13), so short-term volatility bears watching. With SPCX's lockup schedule now clearly approaching, further correction through August-September should be considered a live possibility.
👁 Tomorrow's Watch Points
- SK Hynix (SKHYV→SKHY) trading flow — Watch temporary-ticker volume and liquidity patterns ahead of the July 13 regular-ticker conversion; whether the premium over the $170 open holds is key.
- Meta holding $670 — Watch how profit-taking is absorbed after the 15% weekly surge.
- Airline sector weakness spreading — Check whether Delta-driven fuel-cost concerns spread to other carriers (United, American, etc.).
- Further Gilead downside — Watch for a wave of analyst target cuts following the trial failure.
- SPCX $140 support — Seen as the last technical support zone before lockup concerns fully materialize.
💡 Upcoming Events
- 2026-07-13: SK Hynix converts to regular ticker (SKHY), regular-way trading begins
- Early August 2026: SPCX earnings report expected (followed by 20% insider lockup expiration)
📚 Sources
- Stock market today: Dow, S&P 500, Nasdaq rise to cap choppy week as SK Hynix pops in US debut — Yahoo Finance
- Meta's stock has best week since early 2024 as optimism builds around AI strategy — CNBC
- Meta Platforms Jumps 6% on AI Cloud Ambitions: Can It Challenge Amazon and CoreWeave? — 24/7 Wall St.
- SK Hynix Nasdaq debut: ADR opens at $170 after $26.5B offering — Quartz
- Delta Air Lines Stock Slides Despite Upbeat Q2 — Schaeffer's Investment Research
- Delta's Earnings May Beat, But Guidance Sets The Test — Finimize
- Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Jul 10 — TradingKey
- SpaceX Stock Slides As Debt Markets Flash Warning Signs — Forbes
- United States Initial Jobless Claims — Trading Economics